Article Text

PDF
AB0106 Celecoxib Induces both Apoptotic and Autophagic Cell Death in Rheumatoid Arthritis Fibroblast-like Synoviocytes
  1. S.-H. Kim1,
  2. J. Bang2,
  3. Y.S. Kim3,
  4. H.-S. Kim4,
  5. S.-J. Hong5,
  6. S.-S. Kim6,
  7. H.-J. Jeong1,
  8. C.-N. Son1,
  9. J.-M. Kim1
  1. 1Division of Rheumatology, Department of Internal Medicine, Keimyung University School of Medicine, Dongsan Medical Center
  2. 2Keimyung University Graduate School of Medicine, Daegu
  3. 3Division of Rheumatology, Department of Internal Medicine, Chosun University Hospital, Gwangju
  4. 4Division of Rheumatology, Department of Internal Medicine, Soonchunhyang University Seoul Hospital
  5. 5Division of Rheumatology, Department of Internal Medicine, Kyung Hee University School of Medicine, Seoul
  6. 6Division of Rheumatology, Department of Internal Medicine, Ulsan University School of Medicine, GangNeung Asan Hospital, Gangwon-do, Korea, Republic Of

Abstract

Background An aggressive proliferation of synovium is the hallmark of rheumatoid arthritis (RA). Previous studies suggested that resistance of fibroblast-like synoviocytes (FLS) to apoptosis is involved in synovial hyperplasia in the patients with RA. Recently, the possibilities that autophagy regulates apoptosis resistance and hyperplasia of FLS were also presented. Selective cyclooxygenase-2 (COX-2) inhibitor, celecoxib, has been reported to affect apoptosis or autophagy in various cancer cells.

Objectives The aim of this study is to investigate the influence of celecoxib on viability of RAFLS and to reveal how celecoxib affects the viability of RAFLS.

Methods RA synovial tissue was obtained from patients during total knee replacement surgery or arthroscopy. FLS was cultured with celecoxib, caspase inhibitor (z-VAD-fmk) or autophagy inhibitor (3-methyladenine; 3-MA, bafilomycin A1; bafi A1, chloquine; CQ). Cell viability was measured by MTS assay and by cell count using trypan blue staining. The expression of autophagy flux (LC3, p62) and apoptosis related protein (caspase3 and poly (ADP-ribose) polymerases (PARP)) was analyzed by western blot.

Results Celecoxib dose-dependently decreased cell viability (mean IC50 of 120 μM) of RAFLS. Activation of Caspase 3 and PARP cleavage were observed in RAFLS after the treatment with celecoxib. Combination treatment with caspase inhibitor and celecoxib increased cell viability than a single treatment with celecoxib. Celecoxib also increased the expression of LC3II and p62 in RAFLS. Treatment with autophagy inhibitor (3-MA, bafi A1, CQ) restored viability of RAFLS which was decreased by celecoxib.

Conclusions This study demonstrates that both apoptosis and autophagy contribute to celecoxib-induced cell death in RAFLS. Further studies to identify the effects of celecoxib on chronological sequence of autophagy and apoptosis in RAFLS are need.

  1. Kusunoki N, Yamazaki R, Kawai S. Pro-apoptotic effect of nonsteroidal anti-inflammatory drugs on synovial fibroblasts. Mod Rheumatol. 2008;18(6):542–51.

  2. Audo R, Descamps V, Hahne M, Combe B, Morel J. Apoptosis is not the major death mechanism induced by celecoxib on rheumatoid arthritis synovial fibroblasts. Arthritis Res Ther. 2007;9(6):R128.

Acknowledgement None

Disclosure of Interest None declared

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.